GLP1R and Parkinson disease: Other studies indicate that diabetes may exacerbate PD symptoms, whereas GLP-1 can improve PD symptoms in a dose-dependent manner by increasing dopamine levels in the striatum through its direct antioxidant and anti-inflammatory effects, as well as indirectly by lowering blood glucose levels (Filchenkoi et al., 2018).